Global Regulatory Landscape
Related Experiment Video
Updated: Jan 31, 2026

An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
1Pharmaceuticals and Medical Devices Agency (PMDA), Shin-Kasumigaseki Bldg. 3-3-2, Kasumigaseki, Chiyoda-ku, Tokyo, 100-0013, Japan. matsuda-yoshihiro@pmda.go.jp.
Abstract:
Continuous manufacturing (CM) of pharmaceuticals is a rapidly growing approach in the production of active pharmaceutical ingredients and finished products. The European Medicines Agency, the US Food and Drug Administration, and the Pharmaceuticals and Medical Devices Agency have independently stated their support for the introduction of CM and provided opportunities for early dialog between industries and regulatory agencies. This paper describes the current regulatory landscape and the regulatory harmonization.
Related Concept Videos
Global Regulatory Systems
Cis-regulatory Sequences
Cis-regulatory Sequences
Global Climate Change
Introduction to Global Positioning System
Errors in Global Positioning System

